Tempest Therapeutics
TPST
TPST
28 hedge funds and large institutions have $3.94M invested in Tempest Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $4.7M → $3.94M (-$758K)
28% less call options, than puts
Call options by funds: $117K | Put options by funds: $163K
Holders
28
Holding in Top 10
–
Calls
$117K
Puts
$163K
Top Buyers
| 1 | +$763K | |
| 2 | +$92.2K | |
| 3 | +$68.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.4K |
| 5 |
Morgan Stanley
New York
|
+$52.4K |
Top Sellers
| 1 | -$202K | |
| 2 | -$136K | |
| 3 | -$54.9K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$11.2K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$8.6K |